Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin

Figure 2

Effect of ivermectin content on the dimensional characteristics of different liposomal formulations (#PC9-Ch1-ive0.1, #PC9-Ch1-ive0.25, #PC9-Ch1-ive0.5, and #PC9-Ch1-ive1.0 in (a); #PC9-Br1-ive0.1, #PC9-Br1-ive0.25, #PC9-Br1-ive0.5, and #PC9-Br1-ive1.0 in (b)). Empty liposomes composed of PC/cholesterol (a) and PC/DDAB (b). Data refers to -average (filled circles, left -axis), mean by number (open squares, right -axis), and mean by volume (open circles, right -axis). The arrows indicate the -axis relative to the arrowed lines.

(a)

(b)